Jie Wang

Jie Wang

Auto-generated profile, based on publicly available information

Jie Wang

The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao 266071, China

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
CWChao Wang
Chao Wang
YZYujing Zhang
Yujing Zhang
JWJie Wang
Jie Wang
DXDongming Xing
Dongming Xing

1 December 2021 in Journal of Controlled Release
Verified
Journal Article
Closed access
JWJie Wang
Jie Wang
YZYukun Zhang
Yukun Zhang
JPJiuchan Pi
Jiuchan Pi
DXDongming Xing
Dongming Xing
CWChao Wang
Chao Wang

20 December 2023 in Frontiers in Immunology
Verified
Journal Article
Open access
XLXinlin Liu
Xinlin Liu
JLJiyixuan Li
Jiyixuan Li
JDJunwen Deng
Junwen Deng
JZJianan Zhao
Jianan Zhao
GZGaoxiang Zhao
Gaoxiang Zhao
JWJie Wang
Jie Wang
Trophoblast cell surface antigen 2 (Trop2) exhibits limited expression in normal tissues but is over-expressed across various solid tumors. The effectiveness of anti-Trop2 antibody-drug conjugate (ADC) in managing breast cancer validates Trop2 as a promising therapeutic target for cancer treatment. However, excessive toxicity and a low response rate of ADCs pose ongoing challenges. Safer and more effective strategies should be developed for Trop2-positive cancers. The dynamic structural attributes and the oligomeric assembly of Trop2 present formidable obstacles to the progression of innovative targeted therapeutics. In this review, we summarize recent advancements in understanding Trop2’s structure and provide an overview of the epitope characteristics of Trop2-targeted agents. Furthermore, we discuss the correlation between anti-Trop2 agents’ epitopes and their respective functions, particularly emphasizing their efficacy and specificity in targeted therapies.

26 April 2024 in Materials Today Bio
Verified
Journal Article
Open access
JWJie Wang
Jie Wang
ZZZongying Zhang
Zongying Zhang
RLRongxiang Liang
Rongxiang Liang
WCWujun Chen
Wujun Chen
QLQian Li
Qian Li
DXDongming Xing
Dongming Xing
Lymph nodes (LNs) occupy a critical position in initiating and augmenting immune responses, both spatially and functionally. In cancer immunotherapy, tumor-specific vaccines are blooming as a powerful tool to suppress the growth of existing tumors, as well as provide preventative efficacy against tumorigenesis. Delivering these vaccines more efficiently to LNs, where antigen-presenting cells (APCs) and T cells abundantly reside, is under extensive exploration. Formulating vaccines into nanomedicines, optimizing their physiochemical properties, and surface modification to specifically bind molecules expressed on LNs or APCs, are common routes and have brought encouraging outcomes. Alternatively, porous scaffolds can be engineered to attract APCs and provide an environment for them to mature, proliferate and migrate to LNs. A relatively new research direction is inducing the formation of LN-like organoids, which have shown positive relevance to tumor prognosis. Cutting-edge advances in these directions and discussions from a future perspective are given here, from which the up-to-date pattern of cancer vaccination will be drawn to hopefully provide basic guidance to future studies.

6 December 2022 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
JWJie Wang
Jie Wang
PLPing Li
Ping Li
NWNing Wang
Ning Wang
JWJing Wang
Jing Wang
DXDongming Xing
Dongming Xing
Bacteria are small but need big efforts to control.

1 December 1997 in Industrial & Engineering Chemistry Research
Verified
Journal Article
Closed access
JWJie Wang
Jie Wang
ATAkira Tomita
Akira Tomita